This month brought the announcement that cancer treatment system manufacturer Varian Medical Systems will make Georgia its East Coast hub — and the news is further testament to the company’s strong relationship with the state’s R&D ecosystem.
Last year, Varian expanded its longtime local presence by acquiring Atlanta-based Velocity Medical
, a developer of a sophisticated technology platform for managing medical imaging information. Launched out of Emory University, Velocity received pivotal early-stage funding from GRA Ventures, the commercialization arm of GRA.
But the Varian connection to GRA traces back nearly 20 years, when the company made it possible for the Alliance to invest in a state-of-the-art NMR spectrometer at the University of Georgia.
The purchase of the 900 MHz spectrometer gave Georgia one of the most powerful instruments of its kind in the world. Varian also helped create the permanent endowment that allowed UGA to recruit GRA Eminent Scholar Jim Prestegard
“Our expansion in Georgia makes good strategic sense,” says Varian’s Oncology Systems business President Kolleen Kennedy. “The state has made extraordinary strides in university research over the past two decades, and the number and caliber of startups being launched out of university labs is impressive.”d
Varian’s expansion is expected to create up to 100 high-value jobs over the next five years.
Read the announcement from Governor Deal